Tags

Type your tag names separated by a space and hit enter

Long-chain polyunsaturated fatty acids are consumed during allergic inflammation and affect T helper type 1 (Th1)- and Th2-mediated hypersensitivity differently.
Clin Exp Immunol 2010; 160(3):411-9CE

Abstract

Studies have shown that atopic individuals have decreased serum levels of n-3 fatty acids. Indicating these compounds may have a protective effect against allergic reaction and/or are consumed during inflammation. This study investigated whether fish (n-3) or sunflower (n-6) oil supplementation affected T helper type 1 (Th1)- and Th2-mediated hypersensitivity in the skin and airways, respectively, and whether the fatty acid serum profile changed during the inflammatory response. Mice were fed regular chow, chow + 10% fish oil or chow + 10% sunflower oil. Mice were immunized with ovalbumin (OVA) resolved in Th1 or Th2 adjuvant. For Th1 hypersensitivity, mice were challenged with OVA in the footpad. Footpad swelling, OVA-induced lymphocyte proliferation and cytokine production in the draining lymph node were evaluated. In the airway hypersensitivity model (Th2), mice were challenged intranasally with OVA and the resulting serum immunoglobulin (Ig)E and eosinophilic lung infiltration were measured. In the Th1 model, OVA-specific T cells proliferated less and produced less interferon (IFN)-gamma, tumour necrosis factor (TNF) and interleukin (IL)-6 in fish oil-fed mice versus controls. Footpad swelling was reduced marginally. In contrast, mice fed fish oil in the Th2 model produced more OVA-specific IgE and had slightly higher proportions of eosinophils in lung infiltrate. A significant fall in serum levels of long-chain n-3 fatty acids accompanied challenge and Th2-mediated inflammation in Th2 model. Fish oil supplementation affects Th1 and Th2 immune responses conversely; significant consumption of n-3 fatty acids occurs during Th2-driven inflammation. The latter observation may explain the association between Th2-mediated inflammation and low serum levels of n-3 fatty acids.

Authors+Show Affiliations

Food Science, Department of Chemical and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden. sara.johansson@chalmers.seNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20148912

Citation

Johansson, S, et al. "Long-chain Polyunsaturated Fatty Acids Are Consumed During Allergic Inflammation and Affect T Helper Type 1 (Th1)- and Th2-mediated Hypersensitivity Differently." Clinical and Experimental Immunology, vol. 160, no. 3, 2010, pp. 411-9.
Johansson S, Lönnqvist A, Ostman S, et al. Long-chain polyunsaturated fatty acids are consumed during allergic inflammation and affect T helper type 1 (Th1)- and Th2-mediated hypersensitivity differently. Clin Exp Immunol. 2010;160(3):411-9.
Johansson, S., Lönnqvist, A., Ostman, S., Sandberg, A. S., & Wold, A. E. (2010). Long-chain polyunsaturated fatty acids are consumed during allergic inflammation and affect T helper type 1 (Th1)- and Th2-mediated hypersensitivity differently. Clinical and Experimental Immunology, 160(3), pp. 411-9. doi:10.1111/j.1365-2249.2010.04107.x.
Johansson S, et al. Long-chain Polyunsaturated Fatty Acids Are Consumed During Allergic Inflammation and Affect T Helper Type 1 (Th1)- and Th2-mediated Hypersensitivity Differently. Clin Exp Immunol. 2010;160(3):411-9. PubMed PMID: 20148912.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-chain polyunsaturated fatty acids are consumed during allergic inflammation and affect T helper type 1 (Th1)- and Th2-mediated hypersensitivity differently. AU - Johansson,S, AU - Lönnqvist,A, AU - Ostman,S, AU - Sandberg,A-S, AU - Wold,A E, Y1 - 2010/02/10/ PY - 2010/2/13/entrez PY - 2010/2/13/pubmed PY - 2010/7/10/medline SP - 411 EP - 9 JF - Clinical and experimental immunology JO - Clin. Exp. Immunol. VL - 160 IS - 3 N2 - Studies have shown that atopic individuals have decreased serum levels of n-3 fatty acids. Indicating these compounds may have a protective effect against allergic reaction and/or are consumed during inflammation. This study investigated whether fish (n-3) or sunflower (n-6) oil supplementation affected T helper type 1 (Th1)- and Th2-mediated hypersensitivity in the skin and airways, respectively, and whether the fatty acid serum profile changed during the inflammatory response. Mice were fed regular chow, chow + 10% fish oil or chow + 10% sunflower oil. Mice were immunized with ovalbumin (OVA) resolved in Th1 or Th2 adjuvant. For Th1 hypersensitivity, mice were challenged with OVA in the footpad. Footpad swelling, OVA-induced lymphocyte proliferation and cytokine production in the draining lymph node were evaluated. In the airway hypersensitivity model (Th2), mice were challenged intranasally with OVA and the resulting serum immunoglobulin (Ig)E and eosinophilic lung infiltration were measured. In the Th1 model, OVA-specific T cells proliferated less and produced less interferon (IFN)-gamma, tumour necrosis factor (TNF) and interleukin (IL)-6 in fish oil-fed mice versus controls. Footpad swelling was reduced marginally. In contrast, mice fed fish oil in the Th2 model produced more OVA-specific IgE and had slightly higher proportions of eosinophils in lung infiltrate. A significant fall in serum levels of long-chain n-3 fatty acids accompanied challenge and Th2-mediated inflammation in Th2 model. Fish oil supplementation affects Th1 and Th2 immune responses conversely; significant consumption of n-3 fatty acids occurs during Th2-driven inflammation. The latter observation may explain the association between Th2-mediated inflammation and low serum levels of n-3 fatty acids. SN - 1365-2249 UR - https://www.unboundmedicine.com/medline/citation/20148912/Long_chain_polyunsaturated_fatty_acids_are_consumed_during_allergic_inflammation_and_affect_T_helper_type_1__Th1___and_Th2_mediated_hypersensitivity_differently_ L2 - https://doi.org/10.1111/j.1365-2249.2010.04107.x DB - PRIME DP - Unbound Medicine ER -